(Q42435139)

31 October 2017

Monitoring heparin therapy with the activated partial thromboplastin time (English)

1 reference

31 October 2017

Stuart RK

1

1 reference

31 October 2017

Michel A

series ordinal

2

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 March 1971

1 reference

31 October 2017

4

1 reference

Canadian Medical Association Journal

inferred from page(s)

published in

1 reference

31 October 2017

104

1 reference

31 October 2017

5

1 reference

31 October 2017

385-388

1 reference

Some Guidelines for Heparin Therapy of Venous Thromboembolic Disease

31 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1930883

Laboratory control of heparin therapy with the activated partial thromboplastin time test

28 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1930883

Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis

28 May 2018

1 reference

12 December 2020

The partial thromboplastin time (cephalin time) in anticoagulation therapy

1 reference

12 December 2020

Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin

1 reference

12 December 2020

Use of the activated partial thromboplastin time in the control of heparin administration

1 reference

12 December 2020

Activated partial thromboplastin time test in heparin therapy. A study

1 reference

12 December 2020

Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation

1 reference

12 December 2020

Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin

1 reference

12 December 2020

Current concepts: the use of heparin

1 reference

12 December 2020

The use of the cephalin time (partial thromboplastin time) in anticoagulation therapy with heparin

1 reference

12 December 2020

Heparin therapy in thromboembolic disease

1 reference

12 December 2020

The administration of heparin

1 reference

12 December 2020

Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose

1 reference

12 December 2020

Evidence for an antithrombotic effect of Dicumarol

1 reference

12 December 2020

Identifiers

1 reference

31 October 2017

1 reference